Yoseph Shaaltiel
Karmi'el, Z, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sequential Genome Editing and Induced Excision of the Transgene in N. tabacum BY2 Cells.
Journal: Frontiers in plant science
Published: September 16, 2020
Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial.
Journal: Journal of clinical gastroenterology
Published: May 13, 2019
Development and Analytical Characterization of Pegunigalsidase Alfa, a Chemically Cross-Linked Plant Recombinant Human α-Galactosidase-A for Treatment of Fabry Disease.
Journal: Bioconjugate chemistry
Published: April 27, 2018
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy.
Journal: Journal of immunological methods
Published: February 14, 2017
Plant specific N-glycans do not have proven adverse effects in humans.
Journal: Nature biotechnology
Published: July 13, 2016
Establishment of a tobacco BY2 cell line devoid of plant-specific xylose and fucose as a platform for the production of biotherapeutic proteins.
Journal: Plant biotechnology journal
Published: July 03, 2016
A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis.
Journal: Immunobiology
Published: May 28, 2016
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis.
Journal: World journal of gastroenterology
Published: May 25, 2016
Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R.
Journal: Toxicology and applied pharmacology
Published: March 19, 2015
Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience.
Journal: Plant biotechnology journal
Published: March 17, 2015
Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.
Journal: Plant biotechnology journal
Published: December 04, 2014
Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease.
Journal: Molecular genetics and metabolism
Published: June 24, 2014
Last Updated: 09/26/2026